Merajver SD - Search Results

1

Genetic determinants of aggressive breast cancer.

Ventura AC, Merajver SD. Ventura AC, et al. Among authors: merajver sd. Annu Rev Med. 2008;59:199-212. doi: 10.1146/annurev.med.59.060106.184830. Annu Rev Med. 2008. PMID: 17914925 Review.

2

Familial breast cancer. Approaching the isolation of a susceptibility gene.

Weber BL, Abel KJ, Brody LC, Flejter WL, Chandrasekharappa SC, Couch FJ, Merajver SD, Collins FS. Weber BL, et al. Among authors: merajver sd. Cancer. 1994 Aug 1;74(3 Suppl):1013-20. doi: 10.1002/1097-0142(19940801)74:3+<1013::aid-cncr2820741507>3.0.co;2-#. Cancer. 1994. PMID: 8039134 Review.

3

Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.

Couch FJ, Garber J, Kiousis S, Calzone K, Hauser ER, Merajver SD, Frank TS, Boehnke M, Chamberlain JS, Collins FS, et al. Couch FJ, et al. Among authors: merajver sd. J Natl Cancer Inst Monogr. 1995;(17):9-14. J Natl Cancer Inst Monogr. 1995. PMID: 8573462

4

Risk assessment and presymptomatic molecular diagnosis in hereditary breast cancer.

Merajver SD, Petty EM. Merajver SD, et al. Clin Lab Med. 1996 Mar;16(1):139-67. Clin Lab Med. 1996. PMID: 8867588

5

Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: initial experience.

Helvie MA, Roubidoux MA, Weber BL, Merajver SD. Helvie MA, et al. Among authors: merajver sd. AJR Am J Roentgenol. 1997 Jun;168(6):1599-602. doi: 10.2214/ajr.168.6.9168735. AJR Am J Roentgenol. 1997. PMID: 9168735

6

Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.

Merajver SD, Frank TS, Xu J, Pham TM, Calzone KA, Bennett-Baker P, Chamberlain J, Boyd J, Garber JE, Collins FS, et al. Merajver SD, et al. Clin Cancer Res. 1995 May;1(5):539-44. Clin Cancer Res. 1995. PMID: 9816013

7

A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

van Golen KL, Davies S, Wu ZF, Wang Y, Bucana CD, Root H, Chandrasekharappa S, Strawderman M, Ethier SP, Merajver SD. van Golen KL, et al. Among authors: merajver sd. Clin Cancer Res. 1999 Sep;5(9):2511-9. Clin Cancer Res. 1999. PMID: 10499627

8

RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.

van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD. van Golen KL, et al. Among authors: merajver sd. Cancer Res. 2000 Oct 15;60(20):5832-8. Cancer Res. 2000. PMID: 11059780

9

RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells.

van Golen KL, Wu ZF, Qiao XT, Bao L, Merajver SD. van Golen KL, et al. Among authors: merajver sd. Neoplasia. 2000 Sep-Oct;2(5):418-25. doi: 10.1038/sj.neo.7900115. Neoplasia. 2000. PMID: 11191108 Free PMC article.

10

Molecular biology of breast cancer metastasis. Inflammatory breast cancer: clinical syndrome and molecular determinants.

Kleer CG, van Golen KL, Merajver SD. Kleer CG, et al. Among authors: merajver sd. Breast Cancer Res. 2000;2(6):423-9. doi: 10.1186/bcr89. Epub 2000 Jul 11. Breast Cancer Res. 2000. PMID: 11250736 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters